These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36241089)

  • 1. Targeted sphingolipid analysis in chickens suggests different mechanisms of fumonisin toxicity in kidney, lung, and brain.
    Guerre P; Matard-Mann M; Nyvall Collén P
    Food Chem Toxicol; 2022 Dec; 170():113467. PubMed ID: 36241089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Analysis of Sphingolipids in Turkeys Fed Fusariotoxins: First Evidence of Key Changes That Could Help Explain Their Relative Resistance to Fumonisin Toxicity.
    Guerre P; Travel A; Tardieu D
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted sphingolipidomics indicates increased C22-C24:16 ratios of virtually all assayed classes in liver, kidney, and plasma of fumonisin-fed chickens.
    Lassallette E; Collén PN; Guerre P
    Ecotoxicol Environ Saf; 2023 Dec; 268():115697. PubMed ID: 37979349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Sphingolipid Analysis in Heart, Gizzard, and Breast Muscle in Chickens Reveals Possible New Target Organs of Fumonisins.
    Guerre P; Gilleron C; Matard-Mann M; Nyvall Collén P
    Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong Alterations in the Sphingolipid Profile of Chickens Fed a Dose of Fumonisins Considered Safe.
    Tardieu D; Matard-Mann M; Collén PN; Guerre P
    Toxins (Basel); 2021 Oct; 13(11):. PubMed ID: 34822554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.
    Tsunoda M; Sharma RP; Riley RT
    J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
    Merrill AH; van Echten G; Wang E; Sandhoff K
    J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fumonisins alone or mixed with other fusariotoxins increase the C22-24:C16 sphingolipid ratios in chicken livers, while deoxynivalenol and zearalenone have no effect.
    Guerre P; Lassallette E; Beaujardin-Daurian U; Travel A
    Chem Biol Interact; 2024 May; 395():111005. PubMed ID: 38615975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceramide synthase inhibition by fumonisins: a perfect storm of perturbed sphingolipid metabolism, signaling, and disease.
    Riley RT; Merrill AH
    J Lipid Res; 2019 Jul; 60(7):1183-1189. PubMed ID: 31048407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro toxicology of fumonisins and the mechanistic implications.
    Norred WP; Wang E; Yoo H; Riley RT; Merrill AH
    Mycopathologia; 1992 Feb; 117(1-2):73-8. PubMed ID: 1513375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of sphingolipid synthesis modulate interferon (IFN)-gamma-induced intercellular adhesion molecule (ICAM)-1 and human leukocyte antigen (HLA)-DR expression on cultured normal human keratinocytes: possible involvement of ceramide in biologic action of IFN-gamma.
    Wakita H; Nishimura K; Tokura Y; Furukawa F; Takigawa M
    J Invest Dermatol; 1996 Sep; 107(3):336-42. PubMed ID: 8751967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo effects of fumonisin B1-producing and fumonisin B1-nonproducing Fusarium moniliforme isolates are similar: fumonisins B2 and B3 cause hepato- and nephrotoxicity in rats.
    Voss KA; Plattner RD; Riley RT; Meredith FI; Norred WP
    Mycopathologia; 1998; 141(1):45-58. PubMed ID: 9725030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1.
    Soriano JM; González L; Catalá AI
    Prog Lipid Res; 2005 Nov; 44(6):345-56. PubMed ID: 16266752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of sphinganine 1-phosphate as a predictive biomarker for fumonisin exposure and toxicity in mice.
    Kim DH; Yoo HS; Lee YM; Kie JH; Jang S; Oh S
    J Toxicol Environ Health A; 2006 Dec; 69(23):2071-82. PubMed ID: 17060094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fumonisin B1 induces apoptosis in cultured human keratinocytes through sphinganine accumulation and ceramide depletion.
    Tolleson WH; Couch LH; Melchior WB; Jenkins GR; Muskhelishvili M; Muskhelishvili L; McGarrity LJ; Domon O; Morris SM; Howard PC
    Int J Oncol; 1999 May; 14(5):833-43. PubMed ID: 10200332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme.
    Wang E; Ross PF; Wilson TM; Riley RT; Merrill AH
    J Nutr; 1992 Aug; 122(8):1706-16. PubMed ID: 1640265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
    Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH
    J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs.
    Riley RT; An NH; Showker JL; Yoo HS; Norred WP; Chamberlain WJ; Wang E; Merrill AH; Motelin G; Beasley VR
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):105-12. PubMed ID: 8430417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipid biosynthesis de novo by rat hepatocytes in culture. Ceramide and sphingomyelin are associated with, but not required for, very low density lipoprotein secretion.
    Merrill AH; Lingrell S; Wang E; Nikolova-Karakashian M; Vales TR; Vance DE
    J Biol Chem; 1995 Jun; 270(23):13834-41. PubMed ID: 7775441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the organ-specific adverse effects of fumonisin B1: comparison between lung and liver.
    Loiseau N; Polizzi A; Dupuy A; Therville N; Rakotonirainy M; Loy J; Viadere JL; Cossalter AM; Bailly JD; Puel O; Kolf-Clauw M; Bertrand-Michel J; Levade T; Guillou H; Oswald IP
    Arch Toxicol; 2015 Sep; 89(9):1619-29. PubMed ID: 25155190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.